AG
IRMD icon

Algert Global’s iRadimed IRMD Stock Holding History

Algert Global’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98M Sell
72,994
-15,062
-17% -$1.37M 0.08% 411
2026
Q1 		$8.48M Buy
88,056
+2,396
+3% +$240K 0.13% 263
2025
Q4 		$8.33M Buy
85,660
+34,863
+69% +$2.99M 0.13% 266
2025
Q3 		$3.61M Buy
50,797
+23,710
+88% +$1.58M 0.06% 503
2025
Q2 		$1.62M Buy
27,087
+20
+0.1% +$1.1K 0.03% 694
2025
Q1 		$1.42M Sell
27,067
-4,784
-15% -$269K 0.04% 701
2024
Q4 		$1.75M Buy
31,851
+693
+2% +$36.5K 0.04% 651
2024
Q3 		$1.57M Buy
31,158
+4,384
+16% +$202K 0.04% 641
2024
Q2 		$1.18M Buy
26,774
+12,227
+84% +$520K 0.04% 638
2024
Q1 		$640K Sell
14,547
-813
-5% -$35.9K 0.03% 720
2023
Q4 		$729K Sell
15,360
-1,710
-10% -$71.9K 0.03% 704
2023
Q3 		$757K Buy
17,070
+11,710
+218% +$544K 0.04% 628
2023
Q2 		$256K Hold
5,360
– – 0.01% 939
2023
Q1 		$211K Buy
+5,360
New +$195K 0.01% 1019
2022
Q1 		– Sell
-4,790
Closed -$221K – 1244
2021
Q4 		$221K Buy
+4,790
New +$193K 0.03% 819
2020
Q2 		– Sell
-30,152
Closed -$644K – 456
2020
Q1 		$644K Buy
30,152
+500
+2% +$11.9K 0.27% 138
2019
Q4 		$693K Buy
29,652
+15,832
+115% +$370K 0.21% 162
2019
Q3 		$290K Buy
+13,820
New +$282K 0.11% 226
2019
Q1 		– Sell
-8,520
Closed -$208K – 350
2018
Q4 		$208K Sell
8,520
-5,190
-38% -$139K 0.06% 327
2018
Q3 		$509K Buy
+13,710
New +$370K 0.11% 244
2017
Q2 		– Sell
-21,865
Closed -$195K – 326
2017
Q1 		$195K Hold
21,865
– – 0.05% 289
2016
Q4 		$243K Buy
+21,865
New +$235K 0.07% 283

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global's IRMD Position: Q2 2026 in Review

Algert Global reduced its iRadimed (IRMD) stake by 17% in Q2 2026, selling an estimated $1.37M and leaving 72,994 shares worth $6.98M. The position accounts for 0.08% of the portfolio, ranked #411.

Algert Global first reported a position in IRMD in Q4 2016 and has held it in 22 quarters since. The position peaked at $8.48M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Algert Global held 72,994 shares of iRadimed worth $6.98M as of Q2 2026.
  • Algert Global sold 15,062 iRadimed shares in Q2 2026, an estimated $1.37M.
  • iRadimed made up 0.08% of Algert Global's portfolio in Q2 2026, its #411 holding.
  • Algert Global first reported a position in iRadimed in Q4 2016 and has held it in 22 quarters since.
  • Algert Global's iRadimed position peaked at $8.48M in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.